The group of combined familial hyperlipidemia with adipose tissue dysfunction includes genes that are active n adipose tissue and responsible for lipid metabolism there.
1. |
Lohmueller KE et al. (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. |
2. |
Nikiforova MN et al. (2003) RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. |
3. |
Dwight T et al. (2003) Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors. |
4. |
Balthasar N et al. (2004) Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. |
5. |
Wisløff U et al. (2005) Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. |
6. |
Uchida T et al. (2005) Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. |
7. |
Hansen SK et al. (2005) Analysis of separate and combined effects of common variation in KCNJ11 and PPARG on risk of type 2 diabetes. |
8. |
et al. (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. |
9. |
Scott LJ et al. (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. |
10. |
Zeggini E et al. (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. |
11. |
None (1978) Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. |
12. |
None (1973) Effects of parabiosis of obese with diabetes and normal mice. |
13. |
Tartaglia LA et al. (1995) Identification and expression cloning of a leptin receptor, OB-R. |
14. |
Chua SC et al. (1996) Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. |
15. |
Chen H et al. (1996) Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. |
16. |
Lee GH et al. (1996) Abnormal splicing of the leptin receptor in diabetic mice. |
17. |
Considine RV et al. (1996) The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations. |
18. |
None (1996) Reflections on STAT3, STAT5, and STAT6 as fat STATs. |
19. |
Ghilardi N et al. (1996) Defective STAT signaling by the leptin receptor in diabetic mice. |
20. |
Chung WK et al. (1996) Mapping of the OB receptor to 1p in a region of nonconserved gene order from mouse and rat to human. |
21. |
Takaya K et al. (1996) Molecular cloning of rat leptin receptor isoform complementary DNAs--identification of a missense mutation in Zucker fatty (fa/fa) rats. |
22. |
Vaisse C et al. (1996) Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. |
23. |
Winick JD et al. (1996) Identification of microsatellite markers linked to the human leptin receptor gene on chromosome 1. |
24. |
Takaya K et al. (1996) Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat. |
25. |
Chung WK et al. (1996) Genomic structure of the human OB receptor and identification of two novel intronic microsatellites. |
26. |
Golden PL et al. (1997) Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels. |
27. |
Gotoda T et al. (1997) Leptin receptor gene variation and obesity: lack of association in a white British male population. |
28. |
Gloaguen I et al. (1997) Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance. |
29. |
Clément K et al. (1998) A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. |
30. |
Sierra-Honigmann MR et al. (1998) Biological action of leptin as an angiogenic factor. |
31. |
Ducy P et al. (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. |
32. |
Rosmond R et al. (2000) Hypertension in obesity and the leptin receptor gene locus. |
33. |
Quinton ND et al. (2001) A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian women. |
34. |
Wauters M et al. (2001) Leptin receptor gene polymorphisms are associated with insulin in obese women with impaired glucose tolerance. |
36. |
Cohen P et al. (2001) Selective deletion of leptin receptor in neurons leads to obesity. |
37. |
Tian Z et al. (2002) Impaired natural killer (NK) cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation. |
38. |
Bates SH et al. (2003) STAT3 signalling is required for leptin regulation of energy balance but not reproduction. |
39. |
Kaneto H et al. (2004) Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide. |
40. |
Zhang EE et al. (2004) Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism. |
41. |
Morton GJ et al. (2005) Leptin action in the forebrain regulates the hindbrain response to satiety signals. |
42. |
de Luca C et al. (2005) Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes. |
43. |
Park KS et al. (2006) Polymorphisms in the leptin receptor (LEPR)--putative association with obesity and T2DM. |
44. |
Raju SV et al. (2006) Activation of the cardiac ciliary neurotrophic factor receptor reverses left ventricular hypertrophy in leptin-deficient and leptin-resistant obesity. |
45. |
Farooqi IS et al. (2007) Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. |
46. |
Björnholm M et al. (2007) Mice lacking inhibitory leptin receptor signals are lean with normal endocrine function. |
47. |
Richert L et al. (2007) Bone mass in prepubertal boys is associated with a Gln223Arg amino acid substitution in the leptin receptor. |
48. |
Morioka T et al. (2007) Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice. |
49. |
Seo S et al. (2009) Requirement of Bardet-Biedl syndrome proteins for leptin receptor signaling. |
50. |
Sun Q et al. (2010) Genome-wide association study identifies polymorphisms in LEPR as determinants of plasma soluble leptin receptor levels. |
51. |
Duggal P et al. (2011) A mutation in the leptin receptor is associated with Entamoeba histolytica infection in children. |
52. |
Czupryn A et al. (2011) Transplanted hypothalamic neurons restore leptin signaling and ameliorate obesity in db/db mice. |
53. |
Ding L et al. (2012) Endothelial and perivascular cells maintain haematopoietic stem cells. |
54. |
Marie CS et al. (2012) Leptin protects host cells from Entamoeba histolytica cytotoxicity by a STAT3-dependent mechanism. |
55. |
Kunisaki Y et al. (2013) Arteriolar niches maintain haematopoietic stem cell quiescence. |
57. |
Gupta RK et al. (2010) Transcriptional control of preadipocyte determination by Zfp423. |
58. |
Zhang LJ et al. (2015) Innate immunity. Dermal adipocytes protect against invasive Staphylococcus aureus skin infection. |
59. |
Sahin E et al. (2011) Telomere dysfunction induces metabolic and mitochondrial compromise. |
60. |
Michalik L et al. (2001) Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice. |
61. |
Tarrade A et al. (2001) PPARgamma/RXRalpha heterodimers control human trophoblast invasion. |
62. |
Rocchi S et al. (2001) A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity. |
63. |
Rosen ED et al. (2002) C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. |
64. |
Ren D et al. (2002) PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis. |
65. |
Agarwal AK et al. (2002) A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy. |
66. |
Hara M et al. (2002) Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro(12)Ala polymorphism in the PPARgamma gene. |
68. |
Yun Z et al. (2002) Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. |
71. |
Ge K et al. (2002) Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis. |
72. |
Pawliczak R et al. (2002) 85-kDa cytosolic phospholipase A2 mediates peroxisome proliferator-activated receptor gamma activation in human lung epithelial cells. |
73. |
Ardlie KG et al. (2002) Testing for population subdivision and association in four case-control studies. |
74. |
Fajas L et al. (2002) E2Fs regulate adipocyte differentiation. |
75. |
Savage DB et al. (2002) Digenic inheritance of severe insulin resistance in a human pedigree. |
76. |
Marques AR et al. (2002) Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas. |
78. |
Sewter C et al. (2002) Differential effects of adiposity on peroxisomal proliferator-activated receptor gamma1 and gamma2 messenger ribonucleic acid expression in human adipocytes. |
79. |
Girnun GD et al. (2002) APC-dependent suppression of colon carcinogenesis by PPARgamma. |
80. |
Heaney AP et al. (2002) Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas. |
81. |
Yu S et al. (2003) Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. |
82. |
Hegele RA et al. (2002) PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy. |
83. |
Fajas L et al. (2002) The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation. |
84. |
Savage DB et al. (2003) Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma. |
86. |
Ameshima S et al. (2003) Peroxisome proliferator-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth. |
87. |
Welch JS et al. (2003) PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages. |
88. |
Qi C et al. (2003) Transcriptional coactivator PRIP, the peroxisome proliferator-activated receptor gamma (PPARgamma)-interacting protein, is required for PPARgamma-mediated adipogenesis. |
89. |
Nakamichi Y et al. (2003) PPAR-gamma overexpression suppresses glucose-induced proinsulin biosynthesis and insulin release synergistically with pioglitazone in MIN6 cells. |
90. |
Bruemmer D et al. (2003) Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells. |
91. |
Wang C et al. (2003) Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation. |
92. |
Saez E et al. (2003) Genetic deficiency in Pparg does not alter development of experimental prostate cancer. |
93. |
Eriksson J et al. (2003) The effects of the Pro12Ala polymorphism of the PPARgamma-2 gene on lipid metabolism interact with body size at birth. |
94. |
Memisoglu A et al. (2003) Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass. |
95. |
Rosen ED et al. (2003) Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose homeostasis. |
96. |
Masud S et al. (2003) Effect of the peroxisome proliferator activated receptor-gamma gene Pro12Ala variant on body mass index: a meta-analysis. |
97. |
Herzig S et al. (2003) CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-gamma. |
98. |
Song J et al. (2003) Peroxisome proliferator-activated receptor gamma C161T polymorphisms and survival of Japanese patients with immunoglobulin A nephropathy. |
99. |
Hevener AL et al. (2003) Muscle-specific Pparg deletion causes insulin resistance. |
100. |
He W et al. (2003) Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. |
101. |
Orio F et al. (2003) Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome. |
102. |
Kelly D et al. (2004) Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. |
103. |
Evans RM et al. (2004) PPARs and the complex journey to obesity. |
104. |
Akune T et al. (2004) PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. |
105. |
Picard F et al. (2004) Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. |
106. |
Patsouris D et al. (2004) PPARalpha governs glycerol metabolism. |
107. |
Zhang J et al. (2004) Selective disruption of PPARgamma 2 impairs the development of adipose tissue and insulin sensitivity. |
108. |
Hegele RA et al. (2004) Unbuckling lipodystrophy from insulin resistance and hypertension. |
109. |
Tsai YS et al. (2004) Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma. |
110. |
Temelkova-Kurktschiev T et al. (2004) Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2 protects against atherosclerosis. |
111. |
Buzzetti R et al. (2004) The common PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity. |
112. |
Bulotta A et al. (2005) The common -866G/A polymorphism in the promoter region of the UCP-2 gene is associated with reduced risk of type 2 diabetes in Caucasians from Italy. |
113. |
Kim KS et al. (2004) Effects of peroxisome proliferator-activated receptor-gamma 2 Pro12Ala polymorphism on body fat distribution in female Korean subjects. |
114. |
Guan Y et al. (2005) Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption. |
115. |
Pascual G et al. (2005) A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. |
116. |
Uno K et al. (2006) Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity. |
117. |
Hansen L et al. (2006) The Pro12Ala variant of the PPARG gene is a risk factor for peroxisome proliferator-activated receptor-gamma/alpha agonist-induced edema in type 2 diabetic patients. |
118. |
Florez JC et al. (2007) Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone. |
120. |
Lüdtke A et al. (2007) Peroxisome proliferator-activated receptor-gamma C190S mutation causes partial lipodystrophy. |
121. |
Odegaard JI et al. (2007) Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. |
122. |
Wan Y et al. (2007) Maternal PPAR gamma protects nursing neonates by suppressing the production of inflammatory milk. |
123. |
Wan Y et al. (2007) PPAR-gamma regulates osteoclastogenesis in mice. |
124. |
Are A et al. (2008) Enterococcus faecalis from newborn babies regulate endogenous PPARgamma activity and IL-10 levels in colonic epithelial cells. |
125. |
Tang W et al. (2008) White fat progenitor cells reside in the adipose vasculature. |
126. |
Chandra V et al. (2008) Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA. |
127. |
Choi JH et al. (2010) Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. |
128. |
Ryan KK et al. (2011) A role for central nervous system PPAR-γ in the regulation of energy balance. |
129. |
Lu M et al. (2011) Brain PPAR-γ promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones. |
130. |
Choi JH et al. (2011) Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation. |
131. |
Dutchak PA et al. (2012) Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones. |
132. |
Jonker JW et al. (2012) A PPARγ-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis. |
133. |
Cipolletta D et al. (2012) PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells. |
134. |
Banks AS et al. (2015) An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ. |
135. |
OMIM.ORG article Omim 601487 |